Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.

Tumour stromal neovascularization was investigated in 114 invasive and 20 in situ carcinomas of the uterine cervix by staining representative sections with the specific endothelial marker anti CD31 (clone JC/70A, isotope IgG1). A digital image analyser was used to measure the immunoreactivity. The following parameters were determined in the 'hot spots': vessel counts, vessel perimeter and endothelial stained area (expressed per mm2). The results were correlated with clinical and histopathological data. There was no significant relationship between the histopathological findings (tumour histology, tumour differentiation, FIGO stage, presence of lymph node metastasis or lymphovascular space involvement) and the median vessel count. In a univariate analysis all angiogenesis parameters had prognostic value: a higher vascularity was associated with worse prognosis (P < 0.05). Multiple regression analysis showed that vascular permeation (P < 0.001) and the median vessel count (P = 0.005) were the most important prognostic indicators. In the future these criteria may be used for selection of patients for anti-angiogenesis therapy.

[1]  D L Wiggins,et al.  Tumor angiogenesis as a prognostic factor in cervical carcinoma. , 1995, Gynecologic oncology.

[2]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[3]  M. P. Vargas,et al.  Angiogenesis in Uterine Cervical Squamous Cell Carcinoma , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[4]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[5]  M. Mitze,et al.  Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. , 1995, Gynecologic oncology.

[6]  J. Shepherd Cervical and vulva cancer: changes in FIGO definitions of staging , 1996, British journal of obstetrics and gynaecology.

[7]  Y. Chung,et al.  Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[9]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[10]  S. Fox Tumour angiogenesis and prognosis. , 1997, Histopathology.

[11]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[12]  M. Greaves,et al.  Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[13]  R Bicknell,et al.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. , 1992, Journal of clinical pathology.

[14]  J. Arends,et al.  Tumor angiogenesis: an independent prognostic parameter in cervical cancer. , 1996, American journal of obstetrics and gynecology.

[15]  S. Fox,et al.  Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. , 1994, British journal of urology.

[16]  N. Weidner,et al.  Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma , 1993, International journal of cancer.

[17]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[18]  A Reinthaller,et al.  Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. , 1995, Anticancer research.

[19]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[20]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[21]  M. Greaves,et al.  Expression of the CD34 gene in vascular endothelial cells. , 1990, Blood.

[22]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[23]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[24]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.